[HTML][HTML] (-2) proPSA a Index zdravé prostaty (PHI) v predikci výskytu karcinomu prostaty v transrektálních biopsiích

K Ryšánková, V Bartoš, J Krhut, T Albínová… - Česká urologie, 2018 - czechurol.cz
Results: From 129 patients, prostate cancer was diagnosed in 60, 16 met the criteria for high‑
risk carcinoma. Median PHI (63.0 vs. 33.9) did significantly differ between men with and …

[HTML][HTML] Clinical study of prenatal ultrasonography combined with T‑box transcription factor 1 as a biomarker for the diagnosis of congenital heart disease

B Guo, J Xiao, L Li, S Wang… - Molecular Medicine …, 2018 - spandidos-publications.com
Congenital heart disease (CHD) seriously threatens fetal health. Therefore, prenatal
examination to detect deformity is extremely important. The present study aimed to …

Mri-Targeted Transrectal Ultrasound Fusion Prostate Biopsies: A Comparative Study of Cancer Detection Rates in Transperineal Versus Transrectal Approach

T Hassan - 2023 - search.proquest.com
Background: Prostate biopsies are the main exam in prostate cancer diagnosis. The high
rate of infectious complications in transrectal approach and the relative safety of …

Comparison of the performances of two RNA-based geno-sensing principles for the detection of LncPCA3 biomarker

S Takita, A Nabok, D Smith, A Lishchuk - 2021 - shura.shu.ac.uk
The most common prostate cancer (PCa) diagnostics which is based on detection of
prostate-specific antigen (PSA) in blood has specificity limitations often resulting in both …

[PDF][PDF] Lokales Staging mittels [68Ga-] PSMA-11 PET/CT vor Prostatektomie/eingereicht von Sarah Dreer, BSc.

SD Dreer - 2023 - epub.jku.at
Das Prostatakarzinom, welches das häufigste Karzinom des Mannes im Urogenitaltrakt
ausmacht und für das ein höheres Alter ein besonderer Risikofaktor ist, stellt insbesondere …

¿ Es el PCA3 costoefectivo en Latinoamérica y el Caribe?

JA Grández-Urbina, R Pichardo-Rodríguez… - salud pública de …, 2018 - scielo.org.mx
Sr. editor: El Antígeno de Cáncer de Próstata 3 (PCA 3) es un segmento no codificante del
ácido ribonucleico mensajero (ARNm) del gen ubicado en el cromosoma 9q21-22. 1 Se …

Estudio de alta resolución de los factores asociados a la supervivencia en el cáncer de próstata

A Barceló Obrador - 2022 - repositori.uib.es
[spa] La supervivencia de cáncer de próstata es globalmente alta, superior al 80%, pero
existen pocos estudios de supervivencia por estadio, así como de los factores que influyen …

Urinary Metabolomic Fingerprints as a Powerful Tool for the Next Generation of Prostate Cancer Diagnosis

CV Berenguer - 2022 - search.proquest.com
Prostate cancer (PCa) remains the most frequent malignant tumour and a leading cause of
oncological death in men, despite the spectacular advances in molecular medicine …

[引用][C] D issertationsschrift

M Neuhaus

[PDF][PDF] DISCLAIMER/INSTRUCTIONS FOR USE

ERG PCA, RNA SPDEF - providers.bcidaho.com
Medical policy provides general guidance for applying Blue Cross of Idaho benefit plans (for
purposes of medical policy, the terms “benefit plan” and “member contract” are used …